__NUXT_JSONP__("/drugs/Tivantinib", (function(a,b){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"905854-02-6",chebiId:"",chemicalFormula:"C23H19N3O2",definition:"An orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity. c-Met inhibitor ARQ 197 binds to the c-Met protein and disrupts c-Met signal transduction pathways, which may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met protein, the product of the proto-oncogene c-Met, is a receptor tyrosine kinase also known as hepatocyte growth factor receptor (HGFR); this protein is overexpressed or mutated in many tumor cell types and plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis.",fdaUniiCode:"PJ4H73IL17",identifier:"C62437",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C129825","C1967"],synonyms:["(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo(3,2,1-ij)quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione","ARQ 197","ARQ-197","TIVANTINIB",a,"c-Met Inhibitor ARQ 197"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FTivantinib",extension:".json",createdAt:b,updatedAt:b}}],fetch:{},mutations:void 0}}("Tivantinib","2021-10-30T13:42:02.943Z")));